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mxtrapleural pneumonectomy (EPP) is a radical en bloc
resection of the lung, pleura, diaphragm, and pericar-
ium. The inability to separate the fused pleural envelope
rom the central tendon of the diaphragm and the lateral
ortion of the pericardium also mandates resection of these
tructures to preserve the intact pleural envelope. EPP was
riginally developed to treat tuberculous empyema and now
t has become the cornerstone of treatment for select patients
ndergoing multimodality therapy for malignant pleural me-
othelioma (MPM).
MPM is an uncommon disease with only 3000 cases in the
S each year.1 Esophageal and lung cancer are, respectively,
t least 4 and 50 times more common. Few surgeons will treat
ore than a handful of cases over their careers. The Brigham
nd Women’s Hospital (BWH) and Dana Farber Cancer In-
titute (DFCI) in Boston, Massachusetts have gained a large
mount of experience in the treatment of this malignancy.
Early application of EPP to the treatment of MPM was
isappointing. Worn2reported an early series in 1974, but
ith median survival of only 19 months and 5-year survival
f 10%. In 1976, Butchart and coworkers3 reported a series
ith a perioperative mortality rate of 31%, median survival of
0 months, and 5-year survival of 3.5%.
Operative mortality after EPP at BWH declined with in-
reasing experience, from an initial perioperative mortality of
% after the first 18 patients in 19914 to 3.4% after 328
atients reported in 2004.5 Despite advances in surgical tech-
ique, the unfortunate fact remains that nearly all patients
ventually die of recurrent disease within 10 years, although
ore than 50% of patients with favorable prognostic vari-
bles live at least 5 years. Analysis of our late results reveals
hat most recurrences occur in either the abdomen or the
psilateral hemithorax.6
The dose limitation of most adjuvant therapies is systemic
oxicity to the patient. Intraoperative intracavitary heated cis-
latin chemotherapeutic lavage (IOHC) has the advantage of
ermitting higher chemotherapy doses than are possible by
ystemic administration. Studies of IOHC in abdominal ma-
righam and Women’s Hospital, Department of Thoracic Surgery, 75 Fran-
cis Street, Boston, MA.
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oi:10.1053/j.optechstcvs.2006.02.001ignancies, including peritoneal mesothelioma, have been ef-
ective.7,8 Ongoing phase I and II studies of IOHC in combi-
ation with EPP at our institution have shown encouraging
esults.
The conduct of EPP with IOHC can be reduced to the
ollowing 10 basic elements: (1) incision and exposure of the
leura via extended posterolateral thoracotomy; (2) ex-
rapleural dissection to separate the tumor from the chest
all and mediastinum; (3) division of the lateral attachments
f the diaphragm, (4) opening of the pericardium and divi-
ion of the hilar vessels, (5) division of the posterior crus of
he diaphragm and the posterior pericardium, (6) closure
nd division of the main bronchus with en bloc removal of
he lung, pleura, pericardium, and diaphragm; (7) radical
ymphadenectomy of the mediastinal nodes; (8) intracavitary
avage with heated cisplatin chemotherapy plus sodium thio-
ulfate or amifostine for renal protection; (9) diaphragmatic
nd pericardial reconstruction, and (10) closure.
All patients undergo standard intraoperative monitoring
ncluding arterial line, continuous oximetry, and central ve-
ous access. A thoracic epidural catheter is placed preopera-
ively. After induction of anesthesia and placement of a left-
ided double-lumen endotracheal tube, the patient is
ositioned in a left lateral decubitus position in preparation
or an extended right posterolateral thoracotomy.
perative Technique
eft Extrapleural Pneumonectomy
or patients with disease of the contralateral hemithorax, left
xtrapleural pneumonectomy is required. This operation is
echnically similar to that on the right with a few important
ifferences because of the more prominent presence of the
orta, esophageal hiatus, and long extrapericardial course of
he pulmonary artery. First, when the pleura is dissected off
he aorta, it is easy to inadvertently start dissecting behind the
orta. Beginning this part of the dissection on the arch can
revent this problem. Second, the left main pulmonary artery
s divided extrapericardially while the pulmonary veins are
ivided intrapericardially. Finally, although the pericardial
nd diaphragmatic reconstructions are performed in a similar
anner, 250 mL less air is withdrawn from the left cavity,ince it is smaller.
45
46 L. Zellos et al.Figure 1 Incision and exposure of the pleura via extended posterolateral thoracotomy. An extended right posterolateral
thoracotomy incision is made along the bed of the sixth rib. The incision begins 2 cm from the costovertebral junction
posteriorly and extends to the costochondral junction anteriorly. The latissimus and serratus muscles are divided and
the sixth rib is removed. We include previous biopsy sites in the incision, if possible, or excise them separately with a
minimum 1-cm margin to the level of the chest wall fascia.Figure 2 Extrapleural dissection to separate the tumor from the chest wall and mediastinum. The extrapleural dissection
is initiated along the bed of the excised rib and performed with a combination of blunt and sharp dissection as needed.
It is not unusual to discover that a fracture plane between the parietal pleura and the chest wall is the easiest way to get
started at the extreme anterior and posterior portion of the incision. Once the plane is started, finger fracture is used to
extend the planes to the mediastinal reflections at the apex, anteriorly and posteriorly. The dissection is continued in
an extrapleural plane until the right main stem and upper lobe bronchi are visualized. A nasogastric tube facilitates the
identification of the esophagus. The esophagus is separated from the specimen using blunt and sharp scissors dissec-
tion. When the dissection approaches a vessel, sharp technique is preferred to avoid vascular injury. Blunt avulsive
injury to the mammary vessels, azygos vein, subclavian vessels, and superior vena cava can occur since the tumor is
often quite adherent to these vessels.
Treatment of malignant mesothelioma 47Figure 3 Division of the lateral attachments of the diaphragm. The extrapleural dissection proceeds inferiorly and
laterally into the sulcus between the pleura and diaphragm. The diaphragmatic resection begins at the anterior
costochondral angle. The diaphragmatic attachments are avulsed and the peritoneum is dissected off the undersurface
of the diaphragm. The avulsion of the lateral attachments of the diaphragm extends in a circumferential fashion laterally
and posteriorly. The diaphragmatic muscle fibers are dissected off the peritoneum by placing Babcock clamps on the
diaphragm to provide cephalad retraction with blunt caudal dissection on the peritoneum using a sponge stick.
Openings within the peritoneum have little consequence if IOHC is being used, since the cannulae are placed in the
pelvis.
48 L. Zellos et al.Figure 4 Opening the pericardium and division of the hilar vessels. The pericardium is divided anteriorly in a cephalad
direction, starting at the anterior diaphragmatic border. This permits assessment of the inside of the pericardium to
make sure there is no direct invasion of the heart. The inferior pericardial cut is extended in a posterior fashion to view
and protect the inferior vena cava. The pulmonary artery and veins are dissected and divided using the endovascular
stapler guided with the red rubber catheter.
Treatment of malignant mesothelioma 49Figure 5 Division of the posterior crus of the diaphragm and the posterior pericardium. Lateral to the inferior vena cava
and the esophagus, the posterior diaphragmatic attachments are divided from the crural attachments to the transverse
processes of the lumbar vertebrae. Care must be taken not to “buttonhole” the postero-inferior extent of the pleural
envelope as it runs behind the crus. The phrenic vessels are clipped and divided on the undersurface of the crus. The
specimen is retracted anteriorly and the pericardium is opened to the level of the bronchus.Figure 6 Division of the main brohus and radical lymphadenectomy. After dividing the pulmonary veins, pulmonary
artery, and bronchus, the specimen is removed. We use a stapler to reliably close the bronchus before it is divided. The
subcarinal (station 7), tracheobronchial (station 4R), para-esophageal (station 8), inferior pulmonary ligament (station
9), and peridiaphragmatic nodes are found and removed. The entire hemithorax is inspected for hemostasis. Liberal use
of the argon beam coagulator (Valleylab, Boulder, CO) on the chest wall facilitates hemostasis.
50 L. Zellos et al.Figure 7 Intracavitary lavage with heated cisplatin chemotherapy. At this point in the operation, the patient is consid-
ered to be macroscopically free of disease. The incision is partially closed at the anterior and posterior extremes. The
Omni retractor is secured to the bed. The skin is secured to the Omni retractor to create a well. A smoke evacuator is
placed beneath Ioband (3 mol/L, Los Angeles, CA) adhesive drapes to further augment the well. An inflow cannula
attached to the arterial tubing of a standard pump tubing pack is placed in the pelvis while the outflow cannula is
attached to the venous tubing and placed in the chest. The chemotherapy infusion is performed at a rate of 1 liter per
minute at a constant temperature of 42°C for 60 minutes. Temperature sensors are placed on each cannula and in the
patient’s esophagus. The volume of perfusate is adjusted to keep the hemithorax full, thus maximizing surface area
contact. Immediately after completion of the 1-hour cisplatin lavage, sodium thiosulfate infusion is administered via a
bolus injection over 10 minutes, followed by continuous infusion for 6 hours.
Treatment of malignant mesothelioma 51Figure 8 Bronchial buttress. After the chemotherapy perfusion has been completed, an omental flap is prepared through
the defect in the diaphragm. This flap is created using endo-GIA staplers to fashion a vascular pedicle flap to reach the
bronchus. This is not sewn into place until the diaphragm and pericardium have been reconstructed.
52 L. Zellos et al.Figure 9 Diaphragm reconstruction. Two 2-mm impermeable Gore-Tex patches (Gore-Tex Dual Mesh, W.L. Gore and
Associates Inc., Flagstaff, AZ) are stapled to create a dynamic patch with reduced tension along the edges that is tailored
to accommodate the mediastinal structures. Nine interrupted 0 Gore-Tex sutures are then placed along the lateral edge.
The Gore-Tex sutures are first placed through the patch. Both ends of each suture are then brought through the
intercostal space with an awl and tied to a 1-mm polypropylene button (Ethicon, Somerville, NJ) as a buttress.
Treatment of malignant mesothelioma 53Figure 10 The diaphragmatic patch is secured anteriorly, laterally, and posteriorly to the chest wall. Gore-Tex sutures
are passed through the chest wall using a sterile awl and then tied over the buttons.
54 L. Zellos et al.Figure 11 The mediastinal edge of the Gore-Tex diaphragmatic patch is sutured to the inferior cut edge of the
pericardium using 0 Gore-Tex sutures. Attention should be paid to avoid constriction of the inferior vena cava by the
diaphragmatic patch. A wedge cutout of the patch may prevent compression of the inferior vena cava once the heart
displaces into the pneumonectomy space after closure.Figure 12 The pericardium is always reconstructed with a prosthetic patch to prevent cardiac herniation. The pericardial
patch is a 15  20 cm piece of 0.1-mm-thick synthetic membrane (Gore-Tex Pericardial Membrane, WL Gore and
Associates, Inc.). The patch is secured to the superior, anterior, and posterior cut edges of the pericardium, while
inferiorly it is sutured to the diaphragmatic patch with 0 Gore-Tex sutures.
Treatment of malignant mesothelioma 55Figure 13 The pericardial patch should be fenestrated to prevent cardiac tamponade caused by the buildup of serum
beneath the patch. A patch that is made too tight will also produce tamponade physiology, since the heart will not be
able to fill during diastole. The omental fat pad to buttress the bronchus is now placed. A small ellipse of the
diaphragmatic patch is removed in the anterior and medial portion near the pericardium. The width of this slit should
be sufficient to prevent compression of the vascular pedicle flap, but not so large as to allow visceral herniation of the
abdominal contents. The omental flap is secured to the bronchus with interrupted vicryl suture.Figure 14 Closure. The argon beam coagulator is again used to achieve hemostasis, after which the thoracotomy is closed
in the usual fashion to ensure an airtight closure. A small (eg, No. 12 F) red rubber catheter is placed in the
pneumonectomy space to permit mediastinal positioning, which is achieved by removing 1 liter of air for a male patient
and 750 mL for a female patient. The patient is extubated in the operating room. On admission to the intensive care
unit, a radiograph of the chest is obtained to check for midline position of the heart, nasogastric tube, and mediastinal
structures. If these are not midline on the chest radiograph, the mediastinum can be balanced by introducing or
removing air via the red rubber catheter.
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